A new trading day began on November 20, 2023, with Fortress Biotech Inc (NASDAQ: FBIO) stock priced at $2.28, up 33.97% from the previous day of trading. During the day, the shares moved up to $2.84 and dropped to $2.22 before settling in for the closing price of $2.09. FBIO’s price has ranged from $1.24 to $17.40 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 35.52% over the past five years. Meanwhile, its annual earnings per share averaged 13.66%. With a float of $4.51 million, this company’s outstanding shares have now reached $7.37 million.
Let’s look at the performance matrix of the company that is accounted for 187 employees. In terms of profitability, gross margin is +55.26, operating margin of -268.76, and the pretax margin is -281.83.
Fortress Biotech Inc (FBIO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Fortress Biotech Inc is 49.55%, while institutional ownership is 16.77%. The most recent insider transaction that took place on Nov 14, was worth 2,664,776. In this transaction President, CEO & Chairman of this company bought 1,567,515 shares at a rate of $1.70, taking the stock ownership to the 2,597,440 shares. Before that another transaction happened on Nov 14, when Company’s insider bought 147,058 for $1.70, making the entire transaction worth $249,999. This insider now owns 1,130,520 shares in total.
Fortress Biotech Inc (FBIO) Latest Financial update
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.94 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -114.30 while generating a return on equity of -115.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.50% during the next five years compared to 9.51% growth over the previous five years of trading.
Fortress Biotech Inc (NASDAQ: FBIO) Trading Performance Indicators
Here are Fortress Biotech Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -24.57, a number that is poised to hit -2.77 in the next quarter and is forecasted to reach -2.15 in one year’s time.
Technical Analysis of Fortress Biotech Inc (FBIO)
Fortress Biotech Inc (NASDAQ: FBIO) saw its 5-day average volume 3.18 million, a positive change from its year-to-date volume of 0.13 million. As of the previous 9 days, the stock’s Stochastic %D was 59.86%. Additionally, its Average True Range was 0.38.
During the past 100 days, Fortress Biotech Inc’s (FBIO) raw stochastic average was set at 17.12%, which indicates a significant decrease from 97.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 297.98% in the past 14 days, which was higher than the 146.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.23, while its 200-day Moving Average is $7.87. Nevertheless, the first resistance level for the watch stands at $3.02 in the near term. At $3.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.64. If the price goes on to break the first support level at $2.40, it is likely to go to the next support level at $2.00. The third support level lies at $1.78 if the price breaches the second support level.
Fortress Biotech Inc (NASDAQ: FBIO) Key Stats
With a market capitalization of 25.03 million, the company has a total of 8,943K Shares Outstanding. Currently, annual sales are 75,740 K while annual income is -86,580 K. The company’s previous quarter sales were 17,390 K while its latest quarter income was -24,780 K.